<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>52</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>11</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of Circulating Variants during the Beginning,  Middle and the End of the 4th Wave of COVID-19 in Tehran Province, Iran in 2021</title>
    <FirstPage>2621</FirstPage>
    <LastPage>2629</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Akram Sadat</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nazanin Zahra</FirstName>
        <LastName>Shafiei&#x2013;Jandaghi</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Sadeghi</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad</FirstName>
        <LastName>Nejati</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sevrin</FirstName>
        <LastName>Zadheidar</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Talat</FirstName>
        <LastName>Mokhtari-Azad</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jila</FirstName>
        <LastName>Yavarian</LastName>
        <affiliation locale="en_US">1.	Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 2.	Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>13</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Whole viral genome sequencing with next generation sequencing (NGS) technique is useful tool for determining the diversity of variants and mutations of severe acute respiratory syndrome coronavirus 2 (SARS&#x2011;CoV&#x2011;2). In this study we have attempted to characterize the mutations and circulating variants of the SARS-CoV-2 genome during the 4th wave of COVID-19 pandemic in Tehran, Iran in 2021.
&#xD;

Methods: We performed complete genome sequencing of 15 SARS-CoV-2 detected from 15 COVID-19 patients during the 4th wave of COVID-19 pandemic with NGS. Three groups of the patients at the beginning, middle and the end of the 4th wave were compared together.
&#xD;

Results: We detected alpha and delta variants during the 4th wave of the pandemic. The results illustrated a dominance of amino acid substitution D614G in spike, and the most frequent mutants were N&#xAD;-R203K, G204R, S235F, nsp12-P323L, nsp6-G106del, G107del and F108del.
&#xD;

Conclusion: The detection of the virus mutations is a useful procedure for identifying the virus behavior and its genetic evolution in order to improve the efficacy of the monitoring strategies and therapeutic measures.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/30768</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/30768/8115</pdf_url>
  </Article>
</Articles>
